Advertisements



Mylan, Lupin announce positive CHMP opinion for Enbrel biosimilar

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 27th, 2020Related News

Top Analyst Upgrades and Downgrades: American Airlines, Chipotle, Ericsson, Microsoft, Mylan, Novavax, Pfizer, P&G, Qualcomm, Square, Starbucks and More

Friday's top analyst upgrades and downgrades included American Airlines, Chipotle Mexican Grill, Ericsson, Microsoft, Mylan, Novavax, Pfizer, Procter & Gamble, Qualcomm, Square and Starbucks......»»

Category: blogSource: 247wallstMar 27th, 2020Related News

The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer"s Upjohn-Mylan Merger

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 25.) Ra Pha.....»»

Category: earningsSource: benzingaMar 26th, 2020Related News

The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer"s Upjohn-Mylan Merger

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 25.) read more.....»»

Category: blogSource: benzingaMar 26th, 2020Related News

Mylan, Pfizer say combination between Mylan, Upjohn to close in 2H20

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 26th, 2020Related News

Drugmakers Mylan, Pfizer delay merger due to coronavirus outbreak

Drugmaker Mylan NV's merger with Pfizer Inc's off-patent branded drug unit, Upjohn, will now close in the second half of this year, the companies said on Thursday, blaming the coronavirus pandemic for the delay......»»

Category: topSource: reutersMar 26th, 2020Related News

Mylan to waive marketing exclusivity in U.S. for lopinavir/ritonavir

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 25th, 2020Related News

Few concerns weighing on Mylan shares today, says Cantor Fitzgerald

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 25th, 2020Related News

The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA) Centogene NV (NASDAQ: CNTG) Gilead Sciences, Inc. (NA.....»»

Category: earningsSource: benzingaMar 20th, 2020Related News

The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) read more.....»»

Category: blogSource: benzingaMar 20th, 2020Related News

Mylan ramps up manufacturing of hydroxycholoroquine sulfate tablets

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 19th, 2020Related News

Mylan to restart production of hydroxychloroquine

Shares of Mylan were up 6% in trading on Thursday after the drugmaker restarted production of hydroxychloroquine-sulfate tablets, which are being considered as a possible treatment for people with COVID-19. Stephen Hahn, the commis.....»»

Category: topSource: marketwatchMar 19th, 2020Related News

Do Hedge Funds Love Mylan N.V. (MYL)?

Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published this article and pr.....»»

Category: topSource: insidermonkeyMar 11th, 2020Related News

Mylan wins in district court dispute against Sanofi"s Lantus patent

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 10th, 2020Related News

Mylan Pharmaceuticals ULC launches Wixela Inhub in Canada

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 10th, 2020Related News

Mylan, Biocon: FDA accepts BLA for MYL-1402O

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 9th, 2020Related News

Mylan trading resumes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 28th, 2020Related News

Mylan trading halted, volatility trading pause

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 28th, 2020Related News

Are Mylan Results Enough for Investors?

Mylan stock pulled back on Friday after it reported mixed fourth-quarter financial results late Thursday......»»

Category: blogSource: 247wallstFeb 28th, 2020Related News

New CFO named for Mylan merged company

Mylan NV and its merger partner Upjohn have named the CFO of Upjohn to the same role in the combined company. Sanjeev Narula, a 16-year Pfizer (NYSE: PFE) executive, will be CFO when the merger between Upjohn and Mylan NV (Nasdaq: MYL) is completed.....»»

Category: topSource: bizjournalsFeb 28th, 2020Related News